Medical Dialogues
  • Dermatology
Login Register
This site is intended for healthcare professionals only
Login Register
  • MD Brand Connect
  • Vaccine Hub
  • MDTV
    • Breaking News
    • Medical News Today
    • Health News Today
    • Latest
    • Journal Club
    • Medico Legal Update
    • Latest Webinars
    • MD Shorts
    • Health Dialogues
  • Fact Check
  • Health Dialogues
Medical Dialogues
  • Medical News & Guidelines
      • Anesthesiology
      • Cardiology and CTVS
      • Critical Care
      • Dentistry
      • Dermatology
      • Diabetes and Endocrinology
      • ENT
      • Gastroenterology
      • Medicine
      • Nephrology
      • Neurology
      • Obstretics-Gynaecology
      • Oncology
      • Ophthalmology
      • Orthopaedics
      • Pediatrics-Neonatology
      • Psychiatry
      • Pulmonology
      • Radiology
      • Surgery
      • Urology
      • Laboratory Medicine
      • Diet
      • Nursing
      • Paramedical
      • Physiotherapy
  • Health news
      • Doctor News
      • Government Policies
      • Hospital & Diagnostics
      • International Health News
      • Medical Organization News
      • Medico Legal News
      • NBE News
      • NMC News
  • Fact Check
      • Bone Health Fact Check
      • Brain Health Fact Check
      • Cancer Related Fact Check
      • Child Care Fact Check
      • Dental and oral health fact check
      • Diabetes and metabolic health fact check
      • Diet and Nutrition Fact Check
      • Eye and ENT Care Fact Check
      • Fitness fact check
      • Gut health fact check
      • Heart health fact check
      • Kidney health fact check
      • Medical education fact check
      • Men's health fact check
      • Respiratory fact check
      • Skin and hair care fact check
      • Vaccine and Immunization fact check
      • Women's health fact check
  • AYUSH
    • Ayurveda
    • Homeopathy
    • Siddha
    • Unani
    • Yoga
  • State News
      • Andaman and Nicobar Islands
      • Andhra Pradesh
      • Arunachal Pradesh
      • Assam
      • Bihar
      • Chandigarh
      • Chattisgarh
      • Dadra and Nagar Haveli
      • Daman and Diu
      • Delhi
      • Goa
      • Gujarat
      • Haryana
      • Himachal Pradesh
      • Jammu & Kashmir
      • Jharkhand
      • Karnataka
      • Kerala
      • Ladakh
      • Lakshadweep
      • Madhya Pradesh
      • Maharashtra
      • Manipur
      • Meghalaya
      • Mizoram
      • Nagaland
      • Odisha
      • Puducherry
      • Punjab
      • Rajasthan
      • Sikkim
      • Tamil Nadu
      • Telangana
      • Tripura
      • Uttar Pradesh
      • Uttrakhand
      • West Bengal
  • Medical Education
      • Ayush Education News
      • Dentistry Education News
      • Medical Admission News
      • Medical Colleges News
      • Medical Courses News
      • Medical Universities News
      • Nursing education News
      • Paramedical Education News
      • Study Abroad
  • Industry
      • Health Investment News
      • Health Startup News
      • Medical Devices News
      • Pharma News
      • Pharmacy Education News
      • Industry Perspective
  • MDTV
      • Health Dialogues MDTV
      • Health News today MDTV
      • Latest Videos MDTV
      • Latest Webinars MDTV
      • MD shorts MDTV
      • Medical News Today MDTV
      • Medico Legal Update MDTV
      • Top Videos MDTV
      • Health Perspectives MDTV
      • Journal Club MDTV
      • Medical Dialogues Show
This site is intended for healthcare professionals only
LoginRegister
Medical Dialogues
LoginRegister
  • Home
  • Medical news & Guidelines
    • Anesthesiology
    • Cardiology and CTVS
    • Critical Care
    • Dentistry
    • Dermatology
    • Diabetes and Endocrinology
    • ENT
    • Gastroenterology
    • Medicine
    • Nephrology
    • Neurology
    • Obstretics-Gynaecology
    • Oncology
    • Ophthalmology
    • Orthopaedics
    • Pediatrics-Neonatology
    • Psychiatry
    • Pulmonology
    • Radiology
    • Surgery
    • Urology
    • Laboratory Medicine
    • Diet
    • Nursing
    • Paramedical
    • Physiotherapy
  • Health news
    • Doctor News
    • Government Policies
    • Hospital & Diagnostics
    • International Health News
    • Medical Organization News
    • Medico Legal News
    • NBE News
    • NMC News
  • Fact Check
    • Bone Health Fact Check
    • Brain Health Fact Check
    • Cancer Related Fact Check
    • Child Care Fact Check
    • Dental and oral health fact check
    • Diabetes and metabolic health fact check
    • Diet and Nutrition Fact Check
    • Eye and ENT Care Fact Check
    • Fitness fact check
    • Gut health fact check
    • Heart health fact check
    • Kidney health fact check
    • Medical education fact check
    • Men's health fact check
    • Respiratory fact check
    • Skin and hair care fact check
    • Vaccine and Immunization fact check
    • Women's health fact check
  • AYUSH
    • Ayurveda
      • Ayurveda Giuidelines
      • Ayurveda News
    • Homeopathy
      • Homeopathy Guidelines
      • Homeopathy News
    • Siddha
      • Siddha Guidelines
      • Siddha News
    • Unani
      • Unani Guidelines
      • Unani News
    • Yoga
      • Yoga Guidelines
      • Yoga News
  • State News
    • Andaman and Nicobar Islands
    • Andhra Pradesh
    • Arunachal Pradesh
    • Assam
    • Bihar
    • Chandigarh
    • Chattisgarh
    • Dadra and Nagar Haveli
    • Daman and Diu
    • Delhi
    • Goa
    • Gujarat
    • Haryana
    • Himachal Pradesh
    • Jammu & Kashmir
    • Jharkhand
    • Karnataka
    • Kerala
    • Ladakh
    • Lakshadweep
    • Madhya Pradesh
    • Maharashtra
    • Manipur
    • Meghalaya
    • Mizoram
    • Nagaland
    • Odisha
    • Puducherry
    • Punjab
    • Rajasthan
    • Sikkim
    • Tamil Nadu
    • Telangana
    • Tripura
    • Uttar Pradesh
    • Uttrakhand
    • West Bengal
  • Medical Education
    • Ayush Education News
    • Dentistry Education News
    • Medical Admission News
    • Medical Colleges News
    • Medical Courses News
    • Medical Universities News
    • Nursing education News
    • Paramedical Education News
    • Study Abroad
  • Industry
    • Health Investment News
    • Health Startup News
    • Medical Devices News
    • Pharma News
      • CDSCO (Central Drugs Standard Control Organisation) News
    • Pharmacy Education News
    • Industry Perspective
OverviewMechanism of ActionHow To UseUsesBenfitsIndicationsMethod of AdministrationDosage StrengthsDosage FormsDietary RestrictionsContraindicationsWarnings and Precautions for usingAdverse ReactionsSide EffectsUse of Diphenoxylate in Specific PopulationsOverdosage Clinical Pharmacology Clinical StudiesAuthored by Reviewed by References
Diphenoxylate

Diphenoxylate

Indications, Uses, Dosage, Drugs Interactions, Side effects
Diphenoxylate
Medicine Type :
Allopathy
Prescription Type:
Prescription Required
Approval :
DCGI (Drugs Controller General of India)
Schedule
Schedule H
Pharmacological Class:
Opiate agonist,
Therapy Class:
Antidiarrheal,

Diphenoxylate is an Opiate receptor agonist belonging to Antidiarrheal.

Diphenoxylate is an antidiarrheal medication used with atropine to manage diarrhea.

Diphenoxylate is well absorbed from GI tract with 90% absorption. May get distributed in breast milk. It has protein binding of 74-95%. It is rapidly and extensively metabolized in liver and is excreted mainly as metabolites and their conjugates in the feces.

Diphenoxylate shows side effects like Nausea, vomiting, loss of appetite, headache, restlessness, tiredness, confusion, changes in mood, stomach discomfort, Drowsiness or sleepiness, Skin rash.

Diphenoxylate is available in the form of Oral tablets.

Diphenoxylate is available in India, US, China, France, Italy, and Australia.

Diphenoxylate belongs to the Antidiarrheal agent acts as an Opiate receptor agonist.

Diphenoxylate is an opiate receptor agonist that stimulate mu receptors in GI tract to decrease the peristalsis and constrict the sphincters. Diphenoxylate has a direct effect on circular smooth muscle of the bowel, that conceivably results in segmentation and prolongation of gastrointestinal transit time. The clinical antidiarrheal action of diphenoxylate may thus be a consequence of enhanced segmentation that allows increased contact of the intraluminal contents with the intestinal mucosa.

The Onset of action of Diphenoxylate is 45min -1 hour.

The Duration of action of Diphenoxylate is 3-4 hours.

Diphenoxylate is used for the management of diarrhea along with other treatments. This medicine is not recommended for use in children below 2 years of age.

Diphenoxylate is approved for use in the following clinical indications

  • Acute and chronic diarrhea

Diphenoxylate is an antidiarrheal medication used with atropine to manage diarrhea.

  • Acute diarrhea

Adult: Initial dose: 10 mg, followed by 5 mg every 6 hours.

Child:

>12 years: 5 mg three times a day.

9-12 years: 2.5 mg 4 times daily

4-8 years: 2.5 mg three times a day.

  • Chronic diarrhea

Adult: Initial dose: 10 mg followed by 5 mg every 6 hours. Discontinue use if no clinical improvement is noted after 10 days of continuous usage at 20 mg/day. Max: 20 mg/day.

Diphenoxylate is available in various strengths as 2.5mg.
Diphenoxylate is available in the form of Oral Tablet.

Diphenoxylate is contraindicated in patients with

  • Infants and children <4 years

Jaundice, intestinal obstruction.

Diarrhea is associated with pseudomembranous colitis or enterotoxin-producing bacteria.

  • Infectious diarrhea

This medicine is not recommended for use in patients having infectious diarrhea. The symptoms may worsen and get prolonged if this medicine is used in such cases. Any incidence of diarrhea accompanied by the presence of blood or pus in stools and high fever should be promptly reported to the doctor.

  • Driving or operating machinery

The use of this medicine may cause symptoms such as dizziness, drowsiness, etc. in some patients. It is advised that you do not perform any activities such as driving a vehicle or operating machinery if you experience any of these symptoms.

  • Use in children

This medicine is not recommended for use in patients less than 2 years of age since the safety and efficacy of use are not clinically established.

  • Liver diseases

This medicine should be used with caution in patients suffering from liver diseases due to the increased risk of adverse effects. Close monitoring of liver function tests is necessary while receiving this medicine. Appropriate dose adjustments or replacement with a suitable alternative may be required in some cases based on the clinical condition.

  • Kidney diseases

This medicine should be used with caution in patients suffering from kidney diseases due to the increased risk of severe adverse effects. Close monitoring of kidney function tests is necessary while receiving this medicine. Appropriate dose adjustments or replacement with a suitable alternative may be required in some cases based on the clinical condition.

Alcohol Warning

Consumption of alcohol during treatment with this medicine may increase the risk of severe side effects. These side effects may include confusion, dizziness, nausea, vomiting, weakness, and fainting.

Breast Feeding Warning

This medicine is not recommended for use in breastfeeding women unless necessary. The risks and benefits should be discussed with the doctor before taking this medicine.

Pregnancy Warning

This medicine is not recommended for use in pregnant women unless necessary. The risks and benefits should be discussed with the doctor before taking this medicine.

Common

● GI effects, Headache, Drowsiness, Dizziness, Restlessness, Euphoria, Depression, Numbness of the extremities; Hypersensitivity reactions, Swelling of the gums.

The common side effects of Diphenoxylate include the following

Common side effects

  • Nausea, Vomiting, Loss of appetite, Headache, Restlessness, Tiredness, Confusion, Changes in mood, Stomach discomfort, Drowsiness or Sleepiness, and Skin rash.

Rare side effects

● Numbness in arms and legs, ongoing pain that begins in the stomach area but may spread to the back, Stomach bloating, Shortness of breath, Hives, Rash, Itching, Swelling of the Eyes, Face, Tongue, Lips, Gums, Mouth, Hands, Feet, Ankles, or Lower legs, Difficulty swallowing or breathing, Hoarseness.

  • Pregnancy

Pregnancy category

Diphenoxylate is not recommended for use in pregnant women unless necessary. The risks and benefits should be discussed with the doctor before taking Diphenoxylate.

  • Nursing Mothers

Diphenoxylate is not recommended for use in breastfeeding women unless necessary. The risks and benefits should be discussed with the doctor before taking Diphenoxylate.

  • Pediatric Use

Diphenoxylate is not recommended for use in patients less than 2 years of age since the safety and efficacy of use are not clinically established.

Symptoms: Atropinism may persist for 2-3 hr (e.g. high fever, generalized flushing, and tachypnoea). Drowsiness, Miosis, Hypotonia, Loss of tendon reflexes, Nystagmus, and Seizures followed by respiratory depression and total apnoea may manifest 12-30 hr after drug ingestion.

Treatment: Empty stomach by emesis or by gastric lavage. Gastric lavage may be effective even after several hr due to decreased GI motility and pylorospasm. Treatment is supportive and symptomatic and monitored closely for 48 hr. Naloxone may be useful in the treatment of severe respiratory depression.

Pharmacodynamic

Diphenoxylate, an antidiarrheal, is effective as adjunctive therapy in the management of diarrhea. Diphenoxylate is rapidly and extensively metabolized in man by ester hydrolysis to diphenoxylic acid (difenoxine), which is biologically active and the major metabolite in the blood.

Pharmacokinetics

  • Absorption

Diphenoxylate is well absorbed from the GI tract with 90% absorption.

  • Distribution

May get distributed in breast milk. It has protein binding of 74-95%.

  • Metabolism and Excretion

It is rapidly and extensively metabolized in the liver and is excreted mainly as metabolites and their conjugates in the feces.

There are some clinical studies of the drug Diphenoxylate mentioned below:
  1. Karim A, Ranney RE, Evensen KL, Clark ML. Pharmacokinetics and metabolism of diphenoxylate in man. Clinical Pharmacology & Therapeutics. 1972 May;13(3):407-19.
  2. MF S. Long-term clinical studies with a new constipating drug, diphenoxylate hydrochloride. North Carolina Medical Journal. 1961 Dec 1;22:600-4.
  3. Xiao L, Lin X, Cao J, Wang X, Wu L. MRI findings in 6 cases of children by inadvertent ingestion of diphenoxylate–atropine. European journal of radiology. 2011 Sep 1;79(3):432-6.
  • https://www.mims.com/india/drug/info/diphenoxylate?type=full&mtype=generic
  • https://medlineplus.gov/druginfo/meds/a601045.html
  • https://go.drugbank.com/drugs/DB01081
  • https://www.practo.com/medicine-info/diphenoxylate-2995-api
undefined
Jyoti Suthar
Jyoti is a Post graduate in Pharmaceutics ( M Pharm) She did her graduation ( B Pharm) From SSR COLLEGE OF PHARMACY And thereafter did her M Pharm specialized in Pharmaceutics from SSR COLLEGE OF PHARMACY
undefined
Dr JUHI SINGLA
Dr JUHI SINGLA has completed her MBBS from Era’s Lucknow Medical college and done MD pharmacology from SGT UNIVERSITY Gurgaon. She can be contacted at editorial@medicaldialogues.in. Contact no. 011-43720751
Published on: 1 Jan 2023 1:29 PM GMT
© 2022 All Rights Reserved.
Powered By: Hocalwire
X
We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok